DUBLIN, June 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" report to their offering.
The global pain management devices market is forecast to reach a value of USD 4.64 Billion by 2021. The growth in this market is primarily driven by factors such as the presence of a large patient population base and adverse effects associated to the use of pain medications.
Based on type, the pain management devices market is categorized into neurostimulation devices (transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS)), ablation devices (RF ablation and cryoablation), and analgesic infusion pumps (intrathecal and external infusion pumps). The neurostimulation devices segment is expected to account for the largest share of the market in 2016. This can majorly be attributed to the cost-effectiveness of neurostimulation devices, high efficacy of TENS and SCS devices in alleviating chronic pain, and availability of reimbursement for SCS therapy in developed countries.
On the basis of applications, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications (pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain). The neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain.
On the basis of mode of purchase, the market is categorized into over-the-counter and prescription-based pain management devices. The prescription-based devices segment is estimated to command a larger share, majorly due to the longer market presence of these devices with established safety and efficacy profiles and their long-term cost effectiveness.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Halyard Health, Inc.
- Hospira, Inc. (A Subsidiary of Pfizer Inc.)
- Medtronic PLC
- Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
- Nevro Corp.
- ST. Jude Medical, Inc.
- Smiths Medical
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Pain Management Devices Market, By Type
8 Global Pain Management Devices Market, By Application
9 Global Pain Management Devices Market, By Mode of Purchase
10 Pain Management Devices Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/lfjt9d/pain_management
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-pain-management-devices-market-value-of-usd-464-billion-by-2021---trends-technologies--opportunities-report-2016-2021---key-vendors-halyard-health-st-jude-medical-medtronic-300286454.html
SOURCE Research and Markets